WATERTOWN, MA, EnPlusOne Biosciences, a biotechnology company harnessing the power of enzymes, announced that it has raised $10 million in additional funding.
EnPlusOne Biosciences, a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, announced that it had raised additional funding to scale and drive continued technical advancements of its ezRNA™ synthesis platform. The round of financing, of approximately $10 million, was led by Northpond Ventures and Breakout Ventures.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
